Preventing Attacks Before They Happen

Jan Lewis Brandes, MD, MS, holds an appointment as an assistant clinical professor in the Department of Neurology, Vanderbilt University School of Medicine, and is the founder and director of the Nashville Neuroscience Group, both in Nashville, Tennessee. After finishing her medical degree at Vanderbilt University School of Medicine, she completed her postgraduate education in neurology, serving as chief resident. Her earlier graduate work centered on molecular virology, as a Fulbright Scholar at the Robert Koch Institute of Virology, Free University of Berlin, and at the University of Tennessee, Knoxville, where she earned a master’s degree in microbiology. She holds board certification from the American Board of Psychiatry and Neurology and has been UCNS-certified in headache medicine.

Dr. Brandes has served as the principal or co-principal investigator in more than 100 clinical trials for headache management. She has authored more than 150 publications in peer-reviewed journals, and her most recent focus has been on expanding enrollment in pregnancy registries, particularly those related to the use of CGRP monoclonal antibodies during pregnancy, and in education regarding hormonal management of migraine.

Dr. Brandes served on the board of directors of the National Headache Foundation for more than a decade, where she was involved in educational programming and patient advocacy. She is a past fellow of the Academy of Neurology, and of the American Headache Society, where she served on the board of directors. She also is the past president of the American Council for Headache Education.